Results 71 to 80 of about 704 (128)

Treatment of Buruli ulcer: research, development, and repurposing of new therapeutics targeting Mycobacterium ulcerans [PDF]

open access: yes
Tese de doutoramento em Ciências da SaúdeMycobacterium ulcerans é o agente patogénico responsável pela Úlcera de Buruli, uma doença infeciosa tropical negligenciada.
Dominguez Enriquez, Juan Pablo
core  

The Decrease in Antibiotic Funding [PDF]

open access: yes, 2015
Tuberculosis (TB) is a bacterial disease treated with antibiotics. But because of the prevalence, nature, and lengthy treatment of the disease, TB is in need of new antibiotics.
Morgan, Gina
core   +1 more source

Diseño de nuevos fármacos y nuevas dianas frente al mycobacterium tuberculosis [PDF]

open access: yes, 2017
La tuberculosis es, hoy día, una amenaza para la salud en todo el mundo. A medida que las cepas de Mycobacterium tuberculosis han ido surgiendo y se han transformado en cepas resistentes, el fracaso del tratamiento es con demasiada frecuencia un hecho ...
Fernández Gil, Álvaro   +1 more
core   +1 more source

Multi-drug resistant tuberculosis in the Netherlands:Personalised treatment and outcome [PDF]

open access: yes, 2016
Tuberculosis (TB) caused by bacilli that are resistant to the two major drugs, rifampicin and isoniazid is defined as Multi-Drug Resistant TB or MDRTB. MDRTB kills around 50% of people affected around the world.
van Altena, Richard
core   +5 more sources

2016 Pipeline Report HIV and TB, Executive Summary [PDF]

open access: yes, 2016
HIV and TB: Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in ...
Mark Harrington
core  

Side-by-Side Profiling of Oxazolidinones to Estimate the Therapeutic Window against Mycobacterial Infections. [PDF]

open access: yesAntimicrob Agents Chemother, 2023
Negatu DA   +4 more
europepmc   +1 more source

Bedaquiline: a new weapon against MDR and XDR-TB [PDF]

open access: yes, 2017
Multidrug-resistant tuberculosis (MDR-TB) is a global public health problem. It requires treatment with combination therapy consisting of four to six drugs including combinations of bactericidal and bacteriostatic drugs, usually for a period of 2 years ...
Garewal, Nipunjot   +3 more
core   +1 more source

Antimicrobial Effect of Oxazolidinones and Its Synergistic Effect with Bedaquiline Against Mycobacterium abscessus Complex. [PDF]

open access: yesInfect Drug Resist, 2023
Gao T   +9 more
europepmc   +1 more source

ANTI-TUBERCULAR ACTIVITY OF EDTA AND HOUSEHOLD CHEMICALS AGAINST MYCOBACTERIUM SMEGMATIS, A SURROGATE FOR MULTI-DRUG RESISTANT TUBERCULOSIS [PDF]

open access: yes, 2015
Drug discovery efforts are increasingly being directed at re-purposing old drugs for use in treatment of multidrug resistant tuberculosis (MDRTB) which continues to pose serious health challenges worldwide.
Fricke, Christine   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy